Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Niemann-Pick Type C disease-related technology available for licensing from NIH

Oct. 30, 1997

Beta3-adrenoceptor agonists reported by Asahi Chemical

Oct. 30, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

New ACAT inhibitors discovered at Mitsubishi Chemical

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Shaman issued U.S. patent for antidiabetic compounds

Oct. 28, 1997

Watson acquires Searle contraceptive products

Oct. 27, 1997

New antidiabetic agents from Boehringer Mannheim

Oct. 24, 1997

Major advance in thalassemia research reported

Oct. 24, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...